Steep Hill Labs and iCan: Israel-Cannabis Announce Joint Venture

March 22, 2017


Steep Hill Labs, Inc. and iCAN: Israel-Cannabis Announce Joint Venture: Steep Hill Israel



In an announcement made March 21 in Tel Aviv at CannaTech, Israel's premier medical cannabis conference, Steep Hill Labs and iCAN: Israel-Cannabis announced the two companies had entered into a joint venture for iCAN to leverage Steep Hill's science, IP, methodology, global collaboration and brand. Steep Hill Israel will empower growers with the technology to breed specific strains, based on genetics and expected chemical profiles for specific patient conditions/diseases.



Click here or the image above to read the full post.



Share on Facebook
Share on Twitter
Please reload

Featured Posts

Investing in Cannabis: Mitch Baruchowitz

May 21, 2019

Please reload

Recent Posts
Please reload